Amarin Corp Plc (AMRN)

[hamkypamky]

ham. I might agree with you if they weren't already selling Lovaza . Its basically the same market ( over half of Lovaza was prescribed off label for CV risk reduction according to last GSK data I saw ) .......so they faze out G Lovaza and replace with G Vascepa ...same sales channel etc .

Yes they sell GenL.
They are far from the only company however, with Apotex and a slew of other GenL makers.

All of these half-dozen generics are fighting for a slice of 2M (and declining) scripts annually.

I doubt TEVA gives genL significant importance considering their massive stable of generics.